Editöre Mektup

Cancer and Artificial Intelligence

Cilt: 5 Sayı: 2 14 Haziran 2024
PDF İndir
EN TR

Cancer and Artificial Intelligence

Öz

Cancer is a multifactorial group of diseases that are known to affect human life with incidence and mortality rates. Artificial Intelligence and the development of new strategies in cancer treatment are of great importance in helping physicians apply optimized treatment tailored to the patient, overcoming both physical and psychological difficulties, and preventing the recurrence and spread of the disease. Thanks to the field of health and Artificial Intelligence, which are integrated with current developments in coordination with each other, great advances have been made and continue to be made in the diagnosis, treatment and prognosis of cancer, one of the major problems of our age.

Anahtar Kelimeler

Kaynakça

  1. 1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021: 71: 209-249.
  2. 2. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263.
  3. 3. Huang S, Yang J, Fong S, Zhao Q. Artificial intelligence in cancer diagnosis and prognosis: Opportunities and challenges. Cancer Lett. 2020;471:61-71.
  4. 4. Hu, C., Liu, X., Zeng, Y. et al. DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application. Clin Epigenet, 2021; 13, 166.
  5. 5. Wong D, Yip S. Machine learning classifies cancer. Nature. 2018; 555(7697):446-447.
  6. 6. Kourou K, Exarchos TP, Exarchos KP, Karamouzis MV, Fotiadis DI. Machine learning applications in cancer prognosis and prediction. Comput Struct Biotechnol J. 2014;13:8-17.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Kanser Tanısı, Kanser Tedavisi (Kemoterapi ve Radyoterapi hariç), Öngörücü ve Prognostik Belirteçler

Bölüm

Editöre Mektup

Erken Görünüm Tarihi

4 Temmuz 2024

Yayımlanma Tarihi

14 Haziran 2024

Gönderilme Tarihi

11 Mayıs 2024

Kabul Tarihi

13 Haziran 2024

Yayımlandığı Sayı

Yıl 2024 Cilt: 5 Sayı: 2

Kaynak Göster

APA
Tutar, L. (2024). Cancer and Artificial Intelligence. Experimental and Applied Medical Science, 5(2), 93-94. https://doi.org/10.46871/eams.1482458
AMA
1.Tutar L. Cancer and Artificial Intelligence. Experimental and Applied Medical Science. 2024;5(2):93-94. doi:10.46871/eams.1482458
Chicago
Tutar, Leyla. 2024. “Cancer and Artificial Intelligence”. Experimental and Applied Medical Science 5 (2): 93-94. https://doi.org/10.46871/eams.1482458.
EndNote
Tutar L (01 Haziran 2024) Cancer and Artificial Intelligence. Experimental and Applied Medical Science 5 2 93–94.
IEEE
[1]L. Tutar, “Cancer and Artificial Intelligence”, Experimental and Applied Medical Science, c. 5, sy 2, ss. 93–94, Haz. 2024, doi: 10.46871/eams.1482458.
ISNAD
Tutar, Leyla. “Cancer and Artificial Intelligence”. Experimental and Applied Medical Science 5/2 (01 Haziran 2024): 93-94. https://doi.org/10.46871/eams.1482458.
JAMA
1.Tutar L. Cancer and Artificial Intelligence. Experimental and Applied Medical Science. 2024;5:93–94.
MLA
Tutar, Leyla. “Cancer and Artificial Intelligence”. Experimental and Applied Medical Science, c. 5, sy 2, Haziran 2024, ss. 93-94, doi:10.46871/eams.1482458.
Vancouver
1.Leyla Tutar. Cancer and Artificial Intelligence. Experimental and Applied Medical Science. 01 Haziran 2024;5(2):93-4. doi:10.46871/eams.1482458